Sort by
Previous Page Page 1 of 3 Next Page
  1. Review

    Functional neuroimaging and chorea: a systematic review

    Chorea is a hyperkinetic movement disorder consisting of involuntary irregular, flowing movements of the trunk, neck or face. Although Huntington’s disease is the most common cause of chorea in adults, chorea ...

    Debra J. Ehrlich and Ruth H. Walker

    Journal of Clinical Movement Disorders 2017 4:8

    Published on: 21 June 2017

  2. Review

    RimabotulinumtoxinB in sialorrhea: systematic review of clinical trials

    The aim of this study was to examine the efficacy, safety and dosing practices of rimabotulinumtoxinB (BoNT-B) for the treatment of patients with sialorrhea based on a systematic review of clinical trials.

    Khashayar Dashtipour, Roongroj Bhidayasiri, Jack J. Chen, Bahman Jabbari, Mark Lew and Diego Torres-Russotto

    Journal of Clinical Movement Disorders 2017 4:9

    Published on: 6 June 2017

  3. Case Report

    Parkinson disease in Gaucher disease

    Gaucher disease (GD) is an inborn error of metabolism caused by mutations in the gene (GBA) coding for glucocerebrosidase (GCase), inherited in an autosomal recessive pattern. GD patients have up to 9% risk of de...

    Federico Rodriguez-Porcel, Alberto J. Espay and Miryam Carecchio

    Journal of Clinical Movement Disorders 2017 4:7

    Published on: 23 May 2017

  4. Review

    Dystonic storm: a practical clinical and video review

    Dystonic storm is a frightening hyperkinetic movement disorder emergency. Marked, rapid exacerbation of dystonia requires prompt intervention and admission to the intensive care unit. Clinical features of dyst...

    Pichet Termsarasab and Steven J. Frucht

    Journal of Clinical Movement Disorders 2017 4:10

    Published on: 28 April 2017

  5. Research article

    Presentation and care of a family with Huntington disease in a resource-limited community

    In high-income countries patients with Huntington disease (HD) typically present to healthcare providers after developing involuntary movements, or for pre-symptomatic genetic testing if at familial risk. A po...

    Jarmal Charles, Lindyann Lessey, Jennifer Rooney, Ingmar Prokop, Katherine Yearwood, Hazel Da Breo, Patrick Rooney, Ruth H. Walker and Andrew K. Sobering

    Journal of Clinical Movement Disorders 2017 4:4

    Published on: 12 April 2017

  6. Research article

    Indirect tolerability comparison of Deutetrabenazine and Tetrabenazine for Huntington disease

    Vesicular monoamine transporter 2 (VMAT2) inhibitors can improve hyperkinetic movements, and are effective treatment options for chorea of Huntington disease (HD). Tetrabenazine was assessed for treating chore...

    Daniel O. Claassen, Benjamin Carroll, Lisa M. De Boer, Eric Wu, Rajeev Ayyagari, Sanjay Gandhi and David Stamler

    Journal of Clinical Movement Disorders 2017 4:3

    Published on: 1 March 2017

  7. Review

    Medical treatment of dystonia

    Therapeutic strategies in dystonia have evolved considerably in the past few decades. Three major treatment modalities include oral medications, botulinum toxin injections and surgical therapies, particularly ...

    Pichet Termsarasab, Thananan Thammongkolchai and Steven J. Frucht

    Journal of Clinical Movement Disorders 2016 3:19

    Published on: 19 December 2016

  8. Commentary

    Novel gene (TMEM230) linked to Parkinson’s disease

    Mutations in six genes are known to cause Parkinson’s disease (PD) (autosomal dominant: alpha-synuclein, LRRK2, VPS35 and autosomal recessive: Parkin, PINK1 and DJ1) and number of other genes are implicated. I...

    Diana A. Olszewska, Conor Fearon and Tim Lynch

    Journal of Clinical Movement Disorders 2016 3:17

    Published on: 15 November 2016

  9. Case report

    Clinical Pearls - how my patients taught me: The fainting lark symptom

    Compulsive movements, complex tics and stereotypies are frequent, especially among patients with autism or psychomotor retardation. These movements can be difficult to characterize and can mimic other conditio...

    A. Kuiper, M.E. van Egmond, M.P.M. Harms, M.D. Oosterhoff, B. van Harten, D.A. Sival, T.J. de Koning and M.A.J. Tijssen

    Journal of Clinical Movement Disorders 2016 3:16

    Published on: 2 November 2016

  10. Review

    Physicians’ role in the determination of fitness to drive in patients with Parkinson’s disease: systematic review of the assessment tools and a call for national guidelines

    Physicians are usually at the forefront when the issue of driving ability is raised by Parkinson’s disease (PD) patients or their family members, even though few have been formally trained in this area.

    Onanong Jitkritsadakul and Roongroj Bhidayasiri

    Journal of Clinical Movement Disorders 2016 3:14

    Published on: 4 October 2016

  11. Research article

    Depressive symptoms can amplify embarrassment in essential tremor

    Embarrassment can be a considerable problem for patients with essential tremor (ET) and is a major motivator for treatment. Depression is also a common feature of ET; as many as 35 % of patients report moderat...

    Elan D. Louis, Stephanie Cosentino and Edward D. Huey

    Journal of Clinical Movement Disorders 2016 3:11

    Published on: 15 July 2016

  12. Case report

    Automatic behavior and communication due to pramipexole

    A 45–year-old woman reported automatic behaviors and communication whilst she was being treated with pramipexole. These episodes vanished after the medication was tapered and she was started on levodopa/carbid...

    Ruth H. Walker

    Journal of Clinical Movement Disorders 2016 3:9

    Published on: 11 July 2016

  13. Research article

    Embouchure dystonia: a video guide to diagnosis and evaluation

    Embouchure dystonia is an unusual focal task-specific dystonia affecting the muscles that control the flow of air into the mouthpiece of a brass or woodwind instrument. The complexity of the embouchure and the...

    Steven J Frucht

    Journal of Clinical Movement Disorders 2016 3:10

    Published on: 18 June 2016

  14. Letter to the Editor

    Cautionary optimism: caffeine and Parkinson’s disease risk

    Most Parkinson’s disease (PD) patients present without known family history and without a diagnosed prodromal phase, underscoring the difficulty of employing primary (neuroprevention) and secondary (neuroprote...

    Leonard L. Sokol, Michael J. Young, Alberto J. Espay and Ronald B. Postuma

    Journal of Clinical Movement Disorders 2016 3:7

    Published on: 6 June 2016

  15. Case report

    Evolution of visual art with dopaminergic therapy

    A patient with right-side-predominant Parkinson’s disease presented visual artwork which improved in resemblance to the model which he was copying with increasing doses of levodopa. I propose that increased do...

    Ruth H. Walker

    Journal of Clinical Movement Disorders 2016 3:6

    Published on: 21 March 2016

  16. Research article

    The effects of dopamine on digit span in Parkinson’s disease

    Parkinson’s disease patients are at an elevated risk of developing cognitive impairment. Although cognitive impairment is one of the strongest predictors of quality of life, dopaminergic anti-parkinsonian medi...

    Clara Warden, Jaclyn Hwang, Anisa Marshall, Michelle Fenesy and Kathleen L. Poston

    Journal of Clinical Movement Disorders 2016 3:5

    Published on: 7 March 2016

Previous Page Page 1 of 3 Next Page